John has over 25 years of life sciences business development experience. He has driven dozens of transactions ranging from discovery stage licensing through to multi-billion dollar mergers & acquisitions.
John is a co-founder and Managing Partner at Shadow Lake Group Inc., a global boutique transaction advisory firm. Prior to co-founding SLG, John was Director of Business Development & Licensing at Mallinckrodt Pharmaceuticals, where he completed a series of transactions through the company’s spin out from Covidien.
John was also Senior Director of Intellectual Property and Licensing at Neuromed Pharmaceuticals. He started his career at the University Industry Liaison Office at the University of British Columbia, where he was responsible for life sciences technology licensing and start-up company formation.
John holds a B.Sc. in Biochemistry from the University of British Columbia.